Covetrus Enters Into Definitive Agreement to Divest scil animal care to Heska

January 16, 2020

Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes.

(Reprint from Covetrus Press Release 1/14/2020) PORTLAND, Maine–(BUSINESS WIRE)–Jan. 14, 2020– Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today announced that it has entered into a definitive agreement to sell its scil animal care business (“scil”) to Heska Corporation (“Heska”) (NASDAQ: HSKA) for a purchase price of $125 million in cash, subject to customary closing adjustments. Read more here.